The abstract is read at the publisher; the summary is JClub's.
A narrative review of 16 papers on first-in-human cell and gene therapy trials in minors finds only one paper directly links clinical care–research tension to therapeutic misconception.
- Why it matters: Pediatric first-in-human trials raise ethical challenges about balancing clinical care goals with research aims, and about how this balance relates to therapeutic misconception.
- What they did: The authors reviewed literature on researcher-clinicians’ responsibilities for cell and gene therapy trials in minors, using inclusion criteria that produced 16 papers, then analyzed how many addressed the similarity vs. difference debate and its connection to therapeutic misconception.
- The result: They argue that therapeutic misconception and clinical equipoise rely on mutually exclusive positions, and propose integrating these concepts into the similarity vs. difference debate while maintaining informed-consent standards in North America.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.